Tacaso Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.30 M
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 15.82%
- Ebitda 15.82%
- Net Worth -11.72%
- Total Assets 0.65%
About Tacaso Pharmaceuticals
Tacaso Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2003 and has a history of 21 years and one month. Its registered office is in Salem, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Govindarajulu Balapadmasri and Balaraman Mohankumar serve as directors at the Company.
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U29297TZ2003PTC028949
- Company No.
028949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2003
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Tacaso Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindarajulu Balapadmasri  | Director | 23-Dec-2010 | Current |
| Balaraman Mohankumar | Director | 10-Dec-2003 | Current |
Financial Performance of Tacaso Pharmaceuticals.
Tacaso Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tacaso Pharmaceuticals?
In 2021, Tacaso Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Omkar Medical Distributors Private LimitedBalaraman Mohankumar is a mutual person
East West Pharma India Private LimitedBalaraman Mohankumar is a mutual person
- Ewp Pharma & Lifecare Remedies Private Limited
Balaraman Mohankumar is a mutual person
Bepees Agro Products Private LimitedGovindarajulu Balapadmasri and Balaraman Mohankumar are mutual person
- Mobanit Industries Private Limited
Govindarajulu Balapadmasri and Balaraman Mohankumar are mutual person
- Natchura Pharma Limited
Govindarajulu Balapadmasri and Balaraman Mohankumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tacaso Pharmaceuticals?
Unlock and access historical data on people associated with Tacaso Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tacaso Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tacaso Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
